Tag: Axial spondyloarthritis prevalence

news-24092024-110718

FDA Approval of Bimekizumab for Psoriatic Arthritis and Axial Spondyloarthritis

Bimekizumab-bkzx, also known as Bimzelx, has recently received FDA approval for the treatment of four chronic immune-mediated inflammatory diseases. These include psoriatic arthritis, nonradiographic...